[1]
2025. Comparative Trial of Furosemide-Spironolactone Combination and Furosemide-Metolazone Combination in Treating Refractory Edema in Nephrotic Syndrome Patients. Indian Journal of Public Health Research & Development. 16, 2 (Mar. 2025), 152–157. DOI:https://doi.org/10.37506/ajvea295.